Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity|
|Citation:||British Journal of Clinical Pharmacology, 2004; 57(1):105-111|
|Publisher:||Blackwell Publishing Ltd|
|Janet K. Coller, Niels Krebsfaenger, Kathrin Klein, Renzo Wolbold, Andreas Nüssler, Peter Neuhaus, Ulrich M. Zanger, Michel Eichelbaum and Thomas E. Mürdter|
|Abstract:||AIMS: To characterize the interindividual variability and the individual CYP involved in the formation of α-hydroxy-, N-desmethyl- and N-didesmethyl-tamoxifen from tamoxifen. METHODS: Microsomes from 50 human livers were used to characterize the interindividual variability in the α-hydroxylation, N-desmethylation and N-didesmethylation of tamoxifen. Selective inhibitors and recombinant enzymes were used to identify the forms of CYP catalysing these reactions. RESULTS: The rates of formation of α-hydroxy-, N-desmethyl- and N-didesmethyl-tamoxifen were highly variable, and correlated with each other (P < 0.0001). The respective ranges were 0.7–11.4, 25.7–411, and below the limit of quantification – 4.4 pmol mg1 protein min1. Formation of all metabolites was observed with expressed recombinant CYP3A4, inhibited by troleandomycin (65, 77 and 35%, respectively, P < 0.05) and associated with CYP3A4 expression (rs = 0.612, rs = 0.585 and rs = 0.430, P < 0.01, respectively). CONCLUSIONS: Formation of α-hydroxy-, N-desmethyl- and N-didesmethyl-tamoxifen in vitro is highly variable and mediated predominantly by CYP3A4.|
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP3A
|Description:||The definitive version is available at www.blackwell-synergy.com|
|Appears in Collections:||Aurora harvest 7|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.